Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/09/sgrx-rises-as-bit-origin-rebrands-to-sangrix-on-nasdaq.jpg

SGRX Rises As Bit Origin Rebrands To Sangrix On Nasdaq​

TIM BOHEN•UPDATED SEP. 5, 2026, 11:36 AM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

SANGRIX Inc Cl A Ord stocks have been trading down by -11.9 percent following reports of weak quarterly sales guidance.

What Traders Need To Know

  • Bit Origin is rebranding to Sangrix, with Class A ordinary shares set to trade on Nasdaq under the new ticker SGRX starting 2026/09/04.
  • The prior Bit Origin name will disappear from Nasdaq screens as the Sangrix identity and SGRX symbol become the primary listing reference.
  • The ticker change to SGRX marks a clean reset of the company’s market identity, which can trigger short-term volatility as traders adjust.
  • Recent price action shows sharp intraday swings and a steady drift lower, underlining the speculative nature of SGRX right now.

Candlestick Chart

Get Free Alerts

Weekly Update Aug 31 – Sep 04, 2026: On Saturday, September 05, 2026 SANGRIX Inc Cl A Ord stock [NASDAQ: SGRX] is trending down by -11.9%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Finance industry expert:

Analyst sentiment – negative

Sangrix (SGRX) is an ultra-early stage, micro-cap financial platform with negligible revenues (~$39k) and extreme valuation risk (price/sales ~49x) relative to no demonstrated profitability. Book value per share of 4.69 and price-to-book of 0.5 suggest deep discount to stated equity, but the capital structure is fragile: retained losses of ~($88m) and only $55k cash. Equity of $3.9m against liabilities of $0.37m and leverage ratio 0.9 indicate modest balance-sheet risk but zero operating return (ROA 0, ROIC -26.23).

Technically, SGRX is in a clear short-term downtrend: successive lower highs and lows from 2.78 to a 1.88 intraday low, with closes compressing below 2.00. Five‑minute candles show persistent selling into bounces, with volume heavier on down candles, confirming distribution. The dominant trend is bearish. A critical actionable level is 2.10–2.20: below this zone, rallies are sellable; only a sustained close back above 2.40 with expanding volume justifies short‑term long exposure.

More Breaking News

The rebranding from Bit Origin to Sangrix and Nasdaq relisting under SGRX create a visibility catalyst but do not change weak fundamentals or the absence of a proven earnings model. Relative to Finance/Capital Markets benchmarks, SGRX trades at venture-like multiples unsupported by cash flow. Near-term resistance sits at 2.40–2.55, with support around 1.80–1.90; failure there opens downside toward 1.50. Verdict: high-risk, speculative trading vehicle only, not an institutional-quality long.

Quick Financial Overview

SANGRIX Inc Cl A Ord, now trading as SGRX, comes into this rebrand with a fragile price structure. The weekly data show a slide from about $2.78 toward $1.95 over recent sessions, with lower highs and lower lows. That is classic downtrend behavior, telling traders that supply has been in control into the ticker change. On a 5‑minute view, the wide intraday range from roughly $3.44 down toward $1.78, closing near $2.10, confirms heavy volatility and thin liquidity.

On the fundamentals, SANGRIX Inc Cl A Ord remains a micro-cap style name. Revenue is around $39,495, with revenue per share under $0.05, yet the price-to-sales ratio sits near 48.88. That means the market is paying almost 49 times sales, which is rich for a business with limited current scale and negative recent multi‑year revenue growth. Book value per share is about $4.69, while recent trading near $2.00 puts SGRX at roughly half of stated book value.

The balance sheet shows total assets of about $3.54M and total liabilities around $372,083, implying modest leverage and positive working capital near $3.16M. Additional paid‑in capital of roughly $74.47M against large negative retained earnings highlights a history of equity funding and accumulated losses. Return on capital around -26.23% reinforces that the business has not yet proven efficient in turning capital into profit. For traders, SGRX is a story where valuation and book value signals are pulling in one direction, while weak profitability and tiny revenues pull in the opposite.

Conclusion

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders